DK0396964T3 - Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner - Google Patents
Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vaccinerInfo
- Publication number
- DK0396964T3 DK0396964T3 DK90107892.3T DK90107892T DK0396964T3 DK 0396964 T3 DK0396964 T3 DK 0396964T3 DK 90107892 T DK90107892 T DK 90107892T DK 0396964 T3 DK0396964 T3 DK 0396964T3
- Authority
- DK
- Denmark
- Prior art keywords
- mutants
- bordetella strains
- pertussis toxin
- development
- producing
- Prior art date
Links
- 108010081690 Pertussis Toxin Proteins 0.000 title abstract 5
- 241000588807 Bordetella Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 102100021277 Beta-secretase 2 Human genes 0.000 abstract 1
- 101710150190 Beta-secretase 2 Proteins 0.000 abstract 1
- 101100083427 Mus musculus Pithd1 gene Proteins 0.000 abstract 1
- 101100109292 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) arg-13 gene Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8920341A IT1230139B (it) | 1989-04-28 | 1989-04-28 | Ceppi di bordetella utili come vaccini antipertosse |
IT01928690A IT1238007B (it) | 1990-02-07 | 1990-02-07 | Mutanti della tossina della pertosse, ceppi di bordetella capaci di produrre detti mutanti e loro impiego per lo sviluppo di vaccini antipertosse |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0396964T3 true DK0396964T3 (da) | 1995-10-30 |
Family
ID=26327122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90107892.3T DK0396964T3 (da) | 1989-04-28 | 1990-04-25 | Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner |
Country Status (10)
Country | Link |
---|---|
US (2) | US7427404B1 (fr) |
EP (1) | EP0396964B1 (fr) |
JP (2) | JP2655583B2 (fr) |
AT (1) | ATE127347T1 (fr) |
CA (1) | CA2015677C (fr) |
DE (1) | DE69022106T2 (fr) |
DK (1) | DK0396964T3 (fr) |
ES (1) | ES2078258T3 (fr) |
GR (1) | GR3018285T3 (fr) |
HK (1) | HK17096A (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP8900132A0 (en) * | 1988-07-22 | 1991-01-14 | Smithkline Biolog | Bordetella pertussis vaccine |
DK0396964T3 (da) * | 1989-04-28 | 1995-10-30 | Sclavo Spa | Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner |
US5786189A (en) * | 1989-11-29 | 1998-07-28 | Smithkline Beecham Biologicals (S.A.) | Vaccine |
IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
DE4113385A1 (de) * | 1991-04-24 | 1992-10-29 | Biotechnolog Forschung Gmbh | Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer |
GB9115332D0 (en) * | 1991-07-16 | 1991-08-28 | Connaught Lab | Manipulation of gene copy number in bordetella |
GB9513371D0 (en) | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
AU7788194A (en) * | 1993-10-05 | 1995-05-01 | Medeva Holdings B.V. | Vaccine compositions |
GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
AU2001271495A1 (en) * | 2000-06-26 | 2002-01-08 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | A high yield pertussis vaccine production strain and method for making same |
GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
BRPI0402630B8 (pt) * | 2004-07-05 | 2021-05-25 | Fund Butantan | processo de obtenção de vacina pertussis celular menos reatogênica |
CA2759681C (fr) * | 2009-04-24 | 2019-09-17 | Kathleen M. Tatti | Detection selective d'especes de bordetella |
US20100317593A1 (en) * | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | 2,3-dihydro-1h-indene compounds |
KR20130072201A (ko) | 2010-03-30 | 2013-07-01 | 피페넥스 인크. | 재조합 독소 단백질의 고수준 발현 |
ES2642138T3 (es) * | 2011-12-21 | 2017-11-15 | Bionet-Asia Co. Ltd | Cepas de Bordetella pertussis modificadas |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
JP2015525794A (ja) | 2012-08-06 | 2015-09-07 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法 |
US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
CA2886938A1 (fr) | 2012-10-12 | 2014-04-17 | Glaxosmithkline Biologicals S.A. | Antigenes de pertussis acellulaires non reticules pour leur utilisation dans des vaccins combines |
BR112015021523A8 (pt) | 2013-03-08 | 2021-06-29 | Crucell Holland Bv | composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis |
AU2014304545A1 (en) | 2013-08-05 | 2016-02-25 | Glaxosmithkline Biologicals S.A. | Combination immunogenic compositions |
KR20170137867A (ko) | 2015-04-16 | 2017-12-13 | 인벤트프라이즈 엘엘씨 | 보르데텔라 퍼투시스 면역원성 백신 조성물 |
AR117191A1 (es) | 2018-11-06 | 2021-07-21 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas |
EP3799884A1 (fr) | 2019-10-01 | 2021-04-07 | GlaxoSmithKline Biologicals S.A. | Compositions immunogènes |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
CA1340373C (fr) * | 1986-01-28 | 1999-02-02 | Rino Rappuoli | Clonage et sequencage du fragment d'adn qui code les cinq sous-unites de l'anatoxine coquelucheuse, plasmide hybride contenant le fragment d'adnet microorganismes transformes par le plasmide hybride et capables d'exprimer toutes les sous-unites de l'anatoxine coquelucheuse ou certaines d'entre elles |
US4883761A (en) * | 1986-03-25 | 1989-11-28 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin gene: cloning and expression of protective antigen |
KR0168039B1 (ko) * | 1987-09-04 | 1999-01-15 | 로버트 디. 웨스트 | 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신 |
US6713072B1 (en) * | 1987-11-02 | 2004-03-30 | Chiron S.R.L. | Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
IT1223334B (it) * | 1987-11-02 | 1990-09-19 | Sclavo Spa | Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse |
US5221618A (en) | 1987-11-24 | 1993-06-22 | Connaught Laboratories Limited | Genetic detoxification of pertussis toxin |
GB8727489D0 (en) * | 1987-11-24 | 1987-12-23 | Connaught Lab | Detoxification of pertussis toxin |
IT1223529B (it) * | 1987-12-18 | 1990-09-19 | Sclavo Spa | Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse |
AP8900132A0 (en) * | 1988-07-22 | 1991-01-14 | Smithkline Biolog | Bordetella pertussis vaccine |
US5000952A (en) * | 1988-08-02 | 1991-03-19 | The Board Of Trustees Of The Leland Stanford, Jr. University | Polypeptide pertussis toxin vaccine |
DK0396964T3 (da) * | 1989-04-28 | 1995-10-30 | Sclavo Spa | Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner |
-
1990
- 1990-04-25 DK DK90107892.3T patent/DK0396964T3/da active
- 1990-04-25 ES ES90107892T patent/ES2078258T3/es not_active Expired - Lifetime
- 1990-04-25 EP EP90107892A patent/EP0396964B1/fr not_active Expired - Lifetime
- 1990-04-25 DE DE69022106T patent/DE69022106T2/de not_active Expired - Lifetime
- 1990-04-25 AT AT90107892T patent/ATE127347T1/de not_active IP Right Cessation
- 1990-04-27 CA CA002015677A patent/CA2015677C/fr not_active Expired - Lifetime
- 1990-05-01 JP JP2111865A patent/JP2655583B2/ja not_active Expired - Lifetime
-
1994
- 1994-06-17 US US08/261,691 patent/US7427404B1/en active Active
-
1995
- 1995-05-02 US US08/431,673 patent/US7666436B1/en active Active
- 1995-12-05 GR GR950403403T patent/GR3018285T3/el unknown
-
1996
- 1996-02-01 HK HK17096A patent/HK17096A/xx not_active IP Right Cessation
- 1996-07-19 JP JP8191142A patent/JP2852025B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7666436B1 (en) | 2010-02-23 |
ES2078258T3 (es) | 1995-12-16 |
JP2852025B2 (ja) | 1999-01-27 |
CA2015677C (fr) | 2005-06-21 |
DE69022106T2 (de) | 1996-02-15 |
CA2015677A1 (fr) | 1990-10-28 |
ATE127347T1 (de) | 1995-09-15 |
US7427404B1 (en) | 2008-09-23 |
GR3018285T3 (en) | 1996-03-31 |
JP2655583B2 (ja) | 1997-09-24 |
JPH03169825A (ja) | 1991-07-23 |
JPH09163978A (ja) | 1997-06-24 |
EP0396964B1 (fr) | 1995-09-06 |
EP0396964A1 (fr) | 1990-11-14 |
DE69022106D1 (de) | 1995-10-12 |
HK17096A (en) | 1996-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0396964T3 (da) | Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner | |
ES2180758T3 (es) | Vacunas de pertussis acelulares y metodos de preparacion de las mismas. | |
DE3853876D1 (de) | Bordetella pertussis-Toxin mit veränderter Toxizität. | |
ATE125568T1 (de) | Analoge der untereinheit des von rekombinanter dns abgeleiteten bordetella-toxins. | |
NL300400I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
DK0425082T3 (da) | Vacciner | |
CA2075711A1 (fr) | Vaccin et methode de fabrication | |
DK365287A (da) | Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner | |
CA2004206A1 (fr) | Methodes de preparation de l'anatoxine coquelucheuse | |
FR2393565A1 (fr) | Procede et dispositif de fixation amovible de protheses, notamment de protheses dentaires | |
DK0550683T3 (da) | Vaccine egnet til bekæmpelse af Borderella pertussis | |
ATE159758T1 (de) | Azelluläre impfstoffe | |
EP0290246A3 (fr) | Vaccin pour provoquer une réponse immunogène des cellules-T protectrice contre le virus de la rage | |
MX9708480A (es) | Vacunas acelulares de pertussis y metodos de preparacion de las mismas. |